Femke A. de Snoo

1.9k total citations
27 papers, 870 citations indexed

About

Femke A. de Snoo is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Femke A. de Snoo has authored 27 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Femke A. de Snoo's work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Genomics and Diagnostics (7 papers). Femke A. de Snoo is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Genomics and Diagnostics (7 papers). Femke A. de Snoo collaborates with scholars based in Netherlands, United States and Italy. Femke A. de Snoo's co-authors include Nelleke A. Gruis, Wilma Bergman, Annuska M. Glas, Lisette Stork‐Sloots, Hans F. A. Vasen, Paul Roepman, Richard A. Bender, D. Timothy Bishop, Martijn H. Breuning and Laura van ‘t Veer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Femke A. de Snoo

27 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Femke A. de Snoo Netherlands 17 556 546 284 178 122 27 870
Michelle A. Gadd United States 10 437 0.8× 426 0.8× 482 1.7× 104 0.6× 157 1.3× 15 1.0k
Sylvie Romain France 16 555 1.0× 411 0.8× 207 0.7× 158 0.9× 169 1.4× 31 857
Hans Halfwerk Netherlands 15 525 0.9× 787 1.4× 553 1.9× 122 0.7× 232 1.9× 19 1.2k
B. Lisboa Germany 12 474 0.9× 376 0.7× 203 0.7× 207 1.2× 54 0.4× 23 788
Lennart Mulder Netherlands 14 442 0.8× 438 0.8× 393 1.4× 250 1.4× 121 1.0× 25 829
Crispinita D. Arroyo United States 12 375 0.7× 220 0.4× 224 0.8× 108 0.6× 107 0.9× 12 663
Gennaro Limite Italy 11 392 0.7× 320 0.6× 146 0.5× 67 0.4× 119 1.0× 32 674
Paolo Squicciarini Italy 11 453 0.8× 549 1.0× 215 0.8× 85 0.5× 321 2.6× 15 918
Elina Eriksson Sweden 13 259 0.5× 286 0.5× 287 1.0× 72 0.4× 129 1.1× 15 653
Anita Langerød Norway 9 484 0.9× 365 0.7× 568 2.0× 111 0.6× 75 0.6× 17 898

Countries citing papers authored by Femke A. de Snoo

Since Specialization
Citations

This map shows the geographic impact of Femke A. de Snoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femke A. de Snoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femke A. de Snoo more than expected).

Fields of papers citing papers by Femke A. de Snoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Femke A. de Snoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femke A. de Snoo. The network helps show where Femke A. de Snoo may publish in the future.

Co-authorship network of co-authors of Femke A. de Snoo

This figure shows the co-authorship network connecting the top 25 collaborators of Femke A. de Snoo. A scholar is included among the top collaborators of Femke A. de Snoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Femke A. de Snoo. Femke A. de Snoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viale, Giuseppe, Femke A. de Snoo, Leen Slaets, et al.. (2017). Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. Breast Cancer Research and Treatment. 167(1). 123–131. 45 indexed citations
2.
Whitworth, Pat W., Peter D. Beitsch, James Pellicane, et al.. (2016). Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping. Annals of Surgical Oncology. 24(3). 669–675. 63 indexed citations
3.
Viale, Giuseppe, Leen Slaets, Femke A. de Snoo, et al.. (2016). Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer. Breast Cancer Research and Treatment. 155(3). 463–469. 16 indexed citations
4.
Baron, Paul L., Peter D. Beitsch, Danielle Boselli, et al.. (2015). Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 23(5). 1522–1529. 24 indexed citations
5.
6.
Drukker, Caroline A., Jelle Wesseling, Harry Bartelink, et al.. (2014). Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis. Breast Cancer Research and Treatment. 148(3). 599–613. 39 indexed citations
7.
Sapino, Anna, Paul Roepman, Sabine C. Linn, et al.. (2014). MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue. Journal of Molecular Diagnostics. 16(2). 190–197. 78 indexed citations
8.
Nieuwpoort, Frans A. van, Jacoba J. Out‐Luiting, Paul J. Hensbergen, et al.. (2012). Genome-Wide Analysis of Gene and Protein Expression of Dysplastic Naevus Cells. Journal of Skin Cancer. 2012. 1–13. 8 indexed citations
9.
Nguyen, Bichlien, P. Cusumano, Kenneth Deck, et al.. (2012). Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients. Annals of Surgical Oncology. 19(10). 3257–3263. 30 indexed citations
10.
Krijgsman, Oscar, Paul Roepman, Wilbert Zwart, et al.. (2011). A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Research and Treatment. 133(1). 37–47. 93 indexed citations
11.
Bender, Richard A. & Femke A. de Snoo. (2011). Clinical Utility of Comprehensive Microarray Testing in Early-stage Breast Cancer. 7(2). 107–107. 2 indexed citations
12.
Snoo, Femke A. de, Hans F. A. Vasen, Wolter J. Mooi, et al.. (2011). Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. Journal of the American Academy of Dermatology. 65(2). 289–296. 12 indexed citations
13.
Bender, Richard A., Michael Knauer, Emiel J. Rutgers, et al.. (2009). The 70-gene profile and chemotherapy benefit in 1,600 breast cancer patients. Journal of Clinical Oncology. 27(15_suppl). 512–512. 12 indexed citations
14.
Snoo, Femke A. de, Jouke‐Jan Hottenga, Elizabeth M. Gillanders, et al.. (2008). Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families. European Journal of Human Genetics. 16(9). 1135–1141. 10 indexed citations
15.
Snoo, Femke A. de, D. Timothy Bishop, Wilma Bergman, et al.. (2008). Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families. Clinical Cancer Research. 14(21). 7151–7157. 128 indexed citations
16.
Snoo, Femke A. de, Sam Riedijk, Anneke M. van Mil, et al.. (2008). Genetic testing in familial melanoma: uptake and implications. Psycho-Oncology. 17(8). 790–796. 21 indexed citations
17.
Snoo, Femke A. de, Marije W. Kroon, Wilma Bergman, et al.. (2007). From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients. Journal of the American Academy of Dermatology. 56(5). 748–752. 10 indexed citations
18.
Harland, Mark, Claire Taylor, Philip Chambers, et al.. (2005). A mutation hotspot at the p14ARF splice site. Oncogene. 24(28). 4604–4608. 52 indexed citations
19.
Riedijk, Sam, Femke A. de Snoo, Sandra van Dijk, et al.. (2005). Hereditary melanoma and predictive genetic testing: why not?. Psycho-Oncology. 14(9). 738–745. 24 indexed citations
20.
Snoo, Femke A. de, Wilma Bergman, & Nelleke A. Gruis. (2003). Familial melanoma: a complex disorder leading to controversy on DNA testing. Familial Cancer. 2(2). 109–116. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle A. Gadd Breakdown of academic impact, for papers by Sylvie Romain Breakdown of academic impact, for papers by Hans Halfwerk Breakdown of academic impact, for papers by B. Lisboa Breakdown of academic impact, for papers by Lennart Mulder Breakdown of academic impact, for papers by Crispinita D. Arroyo Breakdown of academic impact, for papers by Gennaro Limite Breakdown of academic impact, for papers by Paolo Squicciarini Breakdown of academic impact, for papers by Elina Eriksson Breakdown of academic impact, for papers by Anita Langerød
Rankless by CCL
2026